Glory Health Industry Limited released its Monthly Return for April 2026, confirming stable capital structure and continued compliance with Hong Kong Stock Exchange requirements.

Authorised Share Capital • Authorised shares remained at 10.00 billion ordinary shares with a par value of HKD 0.001, equivalent to HKD 10.00 million in authorised capital. • No increase or decrease in authorised or registered share capital was recorded during April.

Issued Share Capital and Treasury Shares • Issued share count stayed unchanged at 4.44 billion shares, with zero treasury shares outstanding. • There were no new share issuances, cancellations, or repurchases during the month.

Public Float Status • The company affirmed that it meets the Exchange’s minimum public-float requirement of 15% of total issued shares as at 30 April 2026.

Equity-linked Instruments and Other Agreements • Glory Health reported no outstanding share options, warrants, convertibles, or other share-issuance arrangements in the period under review.

Governance Confirmation • The board confirmed full compliance with all listing rules, legal obligations, and regulatory filings for the reporting period.

The unchanged capital metrics and confirmation of regulatory compliance suggest operational stability for Glory Health as of end-April 2026.